Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Preparing for unannounced medical device inspections in the EU - are you ready?

This article was originally published in SRA

Executive Summary

Unannounced visits from notified bodies are going to be part of life for medical device manufacturers in the EU. Inspectors arriving unannounced will expect a manufacturer to free up staff to host the visit and make available testing equipment dedicated for their immediate use. There will also be cost implications for device makers. Gert Bos and Françoise Schlemmer explain why it is critical that manufacturers and subcontractors practise and validate protocols for hosting such visits.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel